Recently, documents revealed that Pfizer withheld data about its COVID-19 vaccine from submissions to the FDA. This was highlighted in a report comparing Pfizer's submissions to those sent to Japan. Dr. Byram Bridle, an associate professor of immunology, conducted this analysis, raising serious concerns about the integrity of the regulatory process during the COVID-19 pandemic.
1. Data Withholding: Dr. Bridle's report indicates that crucial data regarding how the vaccine spreads within the body of animals, particularly mice, was not fully disclosed to the FDA. This data suggested broader distribution of the vaccine than initially suggested, contradicting claims that it primarily stays at the injection site and lymph nodes.
2. Questioning Regulatory Integrity: Bridle emphasized that the findings question the reliability and transparency of health regulatory bodies during the pandemic. He claimed that manipulated data was presented to the FDA, which raises concerns about the approval process for the vaccine.
3. Discrepancies in Studies: Pfizer's studies relied on animal testing to estimate biodistribution but failed to provide evidence from human trials. Reports showed the vaccine elements spread to various organs, including kidneys and adrenal glands, contrary to previous assertions.
4. Manipulation of Data: According to the analysis, images submitted to the FDA depicted limited biodistribution and were cropped to obscure key evidence. Full images provided to Japanese regulators showed more extensive spread, indicating a manipulation of data by Pfizer shared with the FDA.
5. Public Health Implications: The CDC has historically claimed that mRNA from vaccines is broken down quickly by the body. However, new research indicates that mRNA and the spike protein may persist in the body longer than previously stated, further complicating the narrative around vaccine safety.
6. Regulatory Oversights: Experts like Charlotte Kuperwasser have called for a reevaluation of vaccine safety, especially concerning reproductive health. Evidence of mRNA's capability to cross the placenta in pregnant mice raised alarms over potential long-term effects on offspring.
7. Changes in Vaccine Recommendations: Following mounting evidence and criticisms, the CDC and FDA have adapted their recommendations, now advising caution in administering COVID-19 vaccines to healthy children and pregnant women.
8. Clinical Studies and Future Research: The FDA's recent decisions reflect emerging clinical evidence suggesting persistent effects of the vaccine's spike protein, which could be associated with long COVID. Future clinical studies are aimed at understanding these implications better.
9. Current Advisory Committee Actions: The CDC's advisory panel expressed concerns about new data on mRNA and DNA persistence from vaccinations. They voted to recommend that individuals consult with healthcare professionals before deciding on vaccination.
The documents revealing data omission by Pfizer raise serious concerns surrounding the COVID-19 vaccination process, questioning the trustworthiness of the information provided to regulatory bodies like the FDA. With emerging evidence suggesting longer-than-expected persistence of vaccine components and potential reproductive implications, health authorities are re-evaluating their recommendations, indicating a significant shift in public health guidance. Ongoing clinical studies are expected to clarify these issues and improve understanding of the vaccines' effects, particularly regarding long-term safety.
No comments:
Post a Comment